e-journal

Understanding genetic variation in in vivo tolerance to artesunate: implications for treatment efficacy and resistance monitoring

---

Artemisinin-based drugs are the front-line weapon in the treatment of human malaria cases, but there is concern that recent reports of slow clearing infections may signal developing resistance to treatment. In the absence of molecular markers for resistance, current efforts to monitor drug efficacy are based on the rate at which parasites are cleared from infections. However, some knowledge of the standing variation in parasite susceptibility is needed to identify a meaningful increase in infection half-life. Here, we show that five previously unexposed genotypes
of the rodent malaria parasite Plasmodium chabaudi differ substantially in their in vivo response to treatment. Slower clearance rates were not linked to parasite virulence or growth rate, going against the suggestion that drug treatment will drive the evolution of virulence in this system. The level of variation observed here in a relatively small number of genotypes suggests existing ‘resistant’ parasites could be present in the population and therefore, increased parasite clearance rates could represent selection on pre-existing variation rather than de novo
resistance events. This has implications for resistance monitoring as susceptibility may depend on evolved traits unrelated to drug exposure.

Keywords
artemisinin, clearance rates, drug resistance,genetic variation, malaria, Plasmodium chabaudi.

---

Ketersediaan

Tidak ada salinan data

Informasi Detail

Judul Seri

Evolutionary Applications

No. Panggil

-

Penerbit

: The Authors., 2015

Deskripsi Fisik

Evolutionary Applications 8 (2015) 296–304

Bahasa

English

ISBN/ISSN

doi:10.1111/eva.1219

Klasifikasi

-

Tipe Isi

-

Tipe Media

-

Tipe Pembawa

-

Edisi

-

Subjek

Agriculture

Info Detail Spesifik

-

Pernyataan Tanggungjawab

Wati/Agus

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus masuk sebelum memberikan komentar